Astec LifeSciences Limited — Results, 31-07-2026: Financial Results Updates

Astec LifeSciences has announced a board meeting where it approved the financial results for the quarter ended June 30, 2026. Following review by the Audit Committee, the company reported consolidated revenue from operations of Rs. 8.36 Cr. However, it incurred a consolidated loss after tax of Rs. 18.71 Cr for the quarter. The Board also noted the Statutory Auditors' limited review reports, which confirmed an unmodified opinion on these results. This update provides investors with critical information on the company's recent operational and financial performance.